Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Pearson

Showing results (131-140 of 169) with videos related to

Pageof 17
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 18, 2022
Cost-Effectiveness of Nadofaragene Firadenovec and Pembrolizumab in Bacillus Calmette-Guérin Immunotherapy Unresponsive Non-Muscle Invasive Bladder CancerMrinmayee Joshi, Steven J Atlas, Molly Beinfeld, et al.
Journal of General Internal Medicine|June 28, 2007
Does affiliation of physician groups with one another produce higher quality primary care?Mark W Friedberg, Kathryn L Coltin, Steven D Pearson, et al.
Journal of Managed Care & Specialty Pharmacy|May 3, 2024
The effectiveness and value of sotatercept for pulmonary arterial hypertension: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory CouncilDmitriy Nikitin, Grace A Lin, Melanie D Whittington, et al.
Journal of Managed Care & Specialty Pharmacy|January 27, 2023
The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory CouncilDmitriy Nikitin, Anil N Makam, Kangho Suh, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 8, 2016
Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysisMelanie D Whittington, R Brett McQueen, Daniel A Ollendorf, et al.
Journal of Managed Care & Specialty Pharmacy|July 5, 2023
Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: Effectiveness and valueAvery McKenna, Grace A Lin, Melanie D Whittington, et al.
Journal of Managed Care & Specialty Pharmacy|April 30, 2020
The Effectiveness and Value of Oral Immunotherapy and Viaskin Peanut for Peanut AllergyJeffrey A Tice, Gregory F Guzauskas, Ryan N Hansen, et al.
Annals of Internal Medicine|June 20, 2013
Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysisJulia H Hayes, Daniel A Ollendorf, Steven D Pearson, et al.
Journal of Managed Care & Specialty Pharmacy|October 25, 2022
The effectiveness and value of betibeglogene autotemcel for the management of transfusion-dependent beta-thalassemiaVictoria Lancaster, Marina Richardson, Francesca L Beaudoin, et al.
Journal of Managed Care & Specialty Pharmacy|April 26, 2022
The effectiveness and value of tezepelumab for severe asthmaDavid M Rind, R Brett McQueen, Serina Herron-Smith, et al.
Pageof 17

Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 18, 2022
Cost-Effectiveness of Nadofaragene Firadenovec and Pembrolizumab in Bacillus Calmette-Guérin Immunotherapy Unresponsive Non-Muscle Invasive Bladder CancerMrinmayee Joshi, Steven J Atlas, Molly Beinfeld, et al.
Journal of General Internal Medicine|June 28, 2007
Does affiliation of physician groups with one another produce higher quality primary care?Mark W Friedberg, Kathryn L Coltin, Steven D Pearson, et al.
Journal of Managed Care & Specialty Pharmacy|May 3, 2024
The effectiveness and value of sotatercept for pulmonary arterial hypertension: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory CouncilDmitriy Nikitin, Grace A Lin, Melanie D Whittington, et al.
Journal of Managed Care & Specialty Pharmacy|January 27, 2023
The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory CouncilDmitriy Nikitin, Anil N Makam, Kangho Suh, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 8, 2016
Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysisMelanie D Whittington, R Brett McQueen, Daniel A Ollendorf, et al.
Journal of Managed Care & Specialty Pharmacy|July 5, 2023
Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: Effectiveness and valueAvery McKenna, Grace A Lin, Melanie D Whittington, et al.
Journal of Managed Care & Specialty Pharmacy|April 30, 2020
The Effectiveness and Value of Oral Immunotherapy and Viaskin Peanut for Peanut AllergyJeffrey A Tice, Gregory F Guzauskas, Ryan N Hansen, et al.
Annals of Internal Medicine|June 20, 2013
Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysisJulia H Hayes, Daniel A Ollendorf, Steven D Pearson, et al.
Journal of Managed Care & Specialty Pharmacy|October 25, 2022
The effectiveness and value of betibeglogene autotemcel for the management of transfusion-dependent beta-thalassemiaVictoria Lancaster, Marina Richardson, Francesca L Beaudoin, et al.
Journal of Managed Care & Specialty Pharmacy|April 26, 2022
The effectiveness and value of tezepelumab for severe asthmaDavid M Rind, R Brett McQueen, Serina Herron-Smith, et al.
Pageof 17